MYMX (MYMX) Stock Price & Analysis
MYMX (MYMX) rose 0.00% to USD 0 as of June 10, 2026 at 02:21 UTC, according to Nexqual real-time market data.
MYMX last closed at USD 0; the session ranged USD 0–0 on volume of 100 shares. Market capitalization is $45, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 02:21 UTC.
Key Statistics (as of June 10, 2026 at 02:21 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 100 shares |
| Market Cap | $45 |
| Exchange | PNK |
Technical Analysis (MYMX)
Nexqual's technical model rates MYMX "BUY" based on 4 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 02:21 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (MYMX)
Wall Street analysts rate MYMX "None", per Nexqual as of June 10, 2026 at 02:21 UTC.
| Consensus Rating | None |
|---|
Earnings (MYMX)
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Financials & Fundamentals (MYMX)
| Total Revenue | $533,000 |
|---|---|
| Revenue Growth (YoY) | -73.80% |
| Gross Margin | -42.21% |
| Operating Margin | -1120.59% |
| Profit Margin | +0.00% |
| Current Ratio | 0 |
| Total Cash | $62,000 |
| Total Debt | $75.11M |
| Free Cash Flow | $-2.18M |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Financial Health Score (MYMX)
Nexqual rates MYMX's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:21 UTC.
| Growth | Critical — Revenue -74% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $62K cash vs $75M debt |
| Cash Flow | Weak — FCF negative: -$2M, burning cash |
| Efficiency | Mixed — No data |
Ownership (MYMX)
| Insider Ownership | +0.11% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 151,878 |
| Float | 73,585 |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Major Backers & Investors (MYMX)
Notable institutional backers of MYMX include IAT Reinsurance Co Ltd, according to Nexqual as of June 10, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| IAT Reinsurance Co Ltd | 0.12% |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PKTX | ProtoKinetix, Inc. | USD 0.01 | ▼ 5.45% |
| MRPI | MERA PHARMACEUTICALS INC | USD 0 | ▲ 0% |
| RGRX | REGENERX BIOPHARMACEUTICALS | USD 0 | ▲ 0% |
| USRM | U.S. Stem Cell, Inc. | USD 0 | ▲ 0% |
| BIOAF | BIOASIS TECHNOLOGIES INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:21 UTC. This page is informational and not investment advice.